![Immunohistochemistry (IHC) analyzes of CYP2A13 (N338) pAb in paraffin-embedded human breast carcinoma tissue at 1:50.showing cytoplasmic staining. Negative control (the right)Using PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG-biotin followed by avidin-peroxidase.](http://www.bioprodhub.com/system/product_images/ab_products/73/sub_1/14977_BS2194_2.jpg)
Immunohistochemistry (IHC) analyzes of CYP2A13 (N338) pAb in paraffin-embedded human breast carcinoma tissue at 1:50.showing cytoplasmic staining. Negative control (the right)Using PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG-biotin followed by avidin-peroxidase.
![Immunohistochemistry (IHC) analyzes of CYP2A13 (N338) pAb in paraffin-embedded human liver carcinoma tissue at 1:50.showing cytoplasmic staining. Negative control (the right)Using PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG](http://www.bioprodhub.com/system/product_images/ab_products/73/sub_1/14978_BS2194_3.jpg)
Immunohistochemistry (IHC) analyzes of CYP2A13 (N338) pAb in paraffin-embedded human liver carcinoma tissue at 1:50.showing cytoplasmic staining. Negative control (the right)Using PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG